Author:
Geisbert T. W.,Bailey M.,Hensley L.,Asiedu C.,Geisbert J.,Stanley D.,Honko A.,Johnson J.,Mulangu S.,Pau M. G.,Custers J.,Vellinga J.,Hendriks J.,Jahrling P.,Roederer M.,Goudsmit J.,Koup R.,Sullivan N. J.
Publisher
American Society for Microbiology
Subject
Virology,Insect Science,Immunology,Microbiology
Reference51 articles.
1. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D;Abbink;J. Virol.,2007
2. Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens;Asmuth;J. Infect. Dis.,2010
3. First-in-human phase 1 safety and immunogenicity of an adenovirus serotype 26 HIV-1 vaccine vector;Barouch,2009
4. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity;Barouch;J. Immunol.,2004
5. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;Buchbinder;Lancet,2008
Cited by
180 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献